Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bedrosian Camille L
Amylyx Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.53%)
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Klee Justin B.
Amylyx Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(4.53%)
Amylyx Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Perceptive Advisors LLC(6.5%),Joseph Edelman(6.5%), etc.
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Klee Justin B.
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Joshua B
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bedrosian Camille L
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mazzariello Gina
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Joshua B
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Joshua B
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer FRATES JAMES M
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Firestone Karen
Amylyx Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer FRATES JAMES M
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILNE GEORGE M JR
Amylyx Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(6.8%),TCG Crossover Fund II, L.P.(6.8%), etc.
Amylyx Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(3.9%)
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FONTEYNE PAUL R.
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Firestone Karen
Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zeiher Bernhardt G
No Data